744 Results (Page 2 of 62)
Medical Devices Markets Research Reports
Egypt ENT Devices Market Analysis
The Egypt ENT Devices Market is projected to grow from $60 Mn in 2022 to $110 Mn by 2030, registering a CAGR of 7.3% during the forecast period of 2022 - 2030. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Egypt ENT devices market include Alfa Medical, Al Amal Medical Supplies, and Misr Medicare.
China ENT Devices Market Analysis
The China ENT Devices Market is projected to grow from $1.86 Bn in 2022 to $3.26 Bn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the China ENT devices market include Beijing Konted Medical Technology, Xuzhou Hengda Electronic, and Shenzhen.
Brazil ENT Devices Market Analysis
The Brazil ENT Devices Market is projected to grow from $580 Mn in 2022 to $980 Mn by 2030, registering a CAGR of 6.8% during the forecast period of 2022 - 2030. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Brazil ENT devices market include KOLPLAST, Newmed, and Soniclease.
Australia ENT Devices Market Analysis
The Australia ENT Devices Market is projected to grow from $280 Mn in 2022 to $490 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Australian ENT devices market include CoreMed ENT, Zonemedical, and Teleflex Medical Australia.
UK Contraceptive Devices Market Analysis
The UK Contraceptive Devices Market is expected to witness growth from $335 Mn in 2022 to $535 Mn in 2030 with a CAGR of 6.00% for the forecasted year 2022-2030. In the UK, people are becoming more aware of and accepting of contraceptive methods. Individuals are more likely to utilise contraceptives to avoid unwanted pregnancies as they become more aware of their alternatives. The market is segmented by type and by gender. Some key players in this market include Consilient Health, Renovos Biologics, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer and Teva Pharmaceutical.
Vietnam Coronary Stents Market Analysis
The Vietnam Coronary Stents Market is expected to witness growth from $57 Mn in 2022 to $83 Mn in 2030 with a CAGR of 4.98% for the forecasted year 2022-2030. A growing number of foreign patients seeking reasonably priced medical treatments, such as coronary stenting, are choosing Vietnam as their destination of choice for medical tourism. The market for coronary stents is anticipated to rise as a result of more medical institutions increasing their product offerings to meet the needs of this market. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Vinamed, VietMedical, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
UK Coronary Stents Market Analysis
The UK Coronary Stents Market is expected to witness growth from $294 Mn in 2022 to $365 Mn in 2030 with a CAGR of 2.75% for the forecasted year 2022-2030. In the UK, coronary artery disease affects a significant number of people, creating a serious health issue. The demand for coronary stents is anticipated to rise as the population ages and risk factors like obesity and diabetes become more common. The market is segmented by type and by gender. Some key players in this market include Renishaw, LivaNova, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
UAE Coronary Stents Market Analysis
The UAE Coronary Stents Market is expected to witness growth from $57 Mn in 2022 to $88 Mn in 2030 with a CAGR of 5.75% for the forecasted year 2022-2030. In the UAE, the prevalence of coronary artery disease is increasing as a result of factors such as poor diet, smoking, and rising obesity rates. As a result, the need for coronary stents to treat the condition is rising. The market is segmented by type and by gender. Some key players in this market include Neopharma, Emirates Biotech Pharmaceutical, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
Turkey Coronary Stents Market Analysis
The Turkey Coronary Stents Market is expected to witness growth from $90 Mn in 2022 to $136 Mn in 2030 with a CAGR of 5.25% for the forecasted year 2022-2030. The demand for coronary stents is anticipated to rise in Turkey as patients and healthcare professionals become more aware of the advantages of coronary stents. Manufacturers who make an investment in educational programmes to spread the word about the advantages of coronary stents may be able to enhance their market share. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Ersamed Medikal, Acibadem Labmed, Megasan Medikal, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
Thailand Coronary Stents Market Analysis
The Thailand Coronary Stents Market is expected to witness growth from $14 Mn in 2022 to $20 Mn in 2030 with a CAGR of 5.09% for the forecasted year 2022-2030. One of the main factors propelling market expansion in Thailand is the increasing incidence and prevalence of coronary artery disease. Demand for coronary stents and related goods is projected to rise as more patients are given a diagnosis of coronary artery disease. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Xovic, Meticuly, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
Tanzania Coronary Stents Market Analysis
The Tanzania Coronary Stents Market is expected to witness growth from $5 Mn in 2022 to $7 Mn in 2030 with a CAGR of 5.65% for the forecasted year 2022-2030. The Tanzanian government has been spending money to upgrade the nation's healthcare system, which includes building more hospitals and clinics. With increased access to medical institutions, especially those performing coronary stent treatments, this investment is likely to spur market expansion. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Zenufa Laboratories, Crown Healthcare, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
Spain Coronary Stents Market Analysis
The Spain Coronary Stents Market is expected to witness growth from $218 Mn in 2022 to $293 Mn in 2030 with a CAGR of 3.75% for the forecasted year 2022-2030. In Spain, procedures involving coronary stents are minimally invasive, which may lead to shorter hospital stays, quicker recoveries, and lower healthcare expenses. As a result, Spain is seeing an increase in the use of minimally invasive techniques, which is fueling the need for coronary stents. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Medlumics, Devicare, Ekuore, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
South Korea Coronary Stents Market Analysis
The South Korea Coronary Stents Market is expected to witness growth from $165 Mn in 2022 to $258 Mn in 2030 with a CAGR of 5.75% for the forecasted year 2022-2030. In South Korea, the frequency of coronary artery illness is increasing which is anticipated to increase demand for coronary stents. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Nanoomtech, Kolon Life Science, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
South Africa Coronary Stents Market Analysis
The South Africa Coronary Stents Market is expected to witness growth from $73 Mn in 2022 to $117 Mn in 2030 with a CAGR of 5.98% for the forecasted year 2022-2030. A greater percentage of the population in South Africa is over 60 years old, signalling an ageing population. This group is more likely to have coronary artery disease, which is projected to boost demand for coronary stents. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include SSEM Mthembu Medical, NuAngle Medical, Tekmed, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
Singapore Coronary Stents Market Analysis
The Singapore Coronary Stents Market is expected to witness growth from $14 Mn in 2022 to $21 Mn in 2030 with a CAGR of 5.35% for the forecasted year 2022-2030. The demand for coronary stents in Singapore is being driven by the increased frequency of cardiovascular disorders such as coronary artery disease and hypertension. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Biosensors International Group, Structo, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
Saudi Arabia Coronary Stents Market Analysis
The Saudi Arabia Coronary Stents Market is expected to witness growth from $192 Mn in 2022 to $312 Mn in 2030 with a CAGR of 6.25% for the forecasted year 2022-2030. In Saudi Arabia, people are becoming more aware of cardiovascular health and are acting more proactively to seek treatment for heart disease. This is increasing demand for coronary stents as patients and medical professionals look for efficient CAD treatments. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Al Madar Medical, Aljeel Medical, Alhammad Medical, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
Poland Coronary Stents Market Analysis
The Poland Coronary Stents Market is expected to witness growth from $66 Mn in 2022 to $98 Mn in 2030 with a CAGR of 5.20% for the forecasted year 2022-2030. The demand for minimally invasive procedures like stenting is increasing as individuals and healthcare professionals look for less invasive treatment choices more frequently. In Poland, the demand for coronary stents is being driven by this trend. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Balton, Metrum Cryoflex, Skamex, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
Philippines Coronary Stents Market Analysis
The Philippines Coronary Stents Market is expected to witness growth from $25 Mn in 2022 to $37 Mn in 2030 with a CAGR of 5.25% for the forecasted year 2022-2030. As cardiovascular disease awareness increases in the Philippines, more patients are seeking early diagnosis and treatment of CAD, which is driving up the demand for coronary stents. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Medasia Medical, S.E.A. Olympus, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
Nigeria Coronary Stents Market Analysis
The Nigeria Coronary Stents Market is expected to witness growth from $10 Mn in 2022 to $16 Mn in 2030 with a CAGR of 5.75% for the forecasted year 2022-2030. Minimally invasive procedures like Percutaneous Coronary Intervention (PCI) are becoming more popular in Nigeria due to their shorter hospital stays, quicker recoveries, and lower costs. This is driving the need for coronary stents as a crucial component of PCI operations. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include AfricaMed, GBioMed, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, JNC International, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
Netherlands Coronary Stents Market Analysis
The Netherlands Coronary Stents Market is expected to witness growth from $29 Mn in 2022 to $44 Mn in 2030 with a CAGR of 5.25% for the forecasted year 2022-2030. The elderly in the Netherlands are becoming more prevalent, which increases their chance of developing coronary artery disease. The demand for coronary stents and other cardiovascular devices is anticipated to rise as the population continues to age. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Hy2Care B.V, InnoSer, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
Mexico Coronary Stents Market Analysis
The Mexico Coronary Stents Market is expected to witness growth from $170 Mn in 2022 to $250 Mn in 2030 with a CAGR of 5.00% for the forecasted year 2022-2030. In Mexico, where the rate and frequency of heart failure are extremely high, it is a significant public health concern. This expands the market for coronary stents and other CAD treatments. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include BIOMEDICA MEXICANA, Medstent, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
Malaysia Coronary Stents Market Analysis
The Malaysia Coronary Stents Market is expected to witness growth from $18 Mn in 2022 to $27 Mn in 2030 with a CAGR of 4.95% for the forecasted year 2022-2030. The introduction of coronary stents as a treatment option for CAD is being driven by a rising desire for minimally invasive procedures in Malaysia because these procedures are less invasive and have quicker recovery times than conventional surgical procedures. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Qualitas Medical Group, GA2 Medical, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
Kenya Coronary Stents Market Analysis
The Kenya Coronary Stents Market is expected to witness growth from $8 Mn in 2022 to $12 Mn in 2030 with a CAGR of 5.85% for the forecasted year 2022-2030. In Kenya, both the incidence and prevalence of coronary artery disease are rising. Since CAD is one of the main conditions requested for the implantation of coronary stents, this is a significant market growth driver for manufacturers of coronary stents. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Apicalmed, Asterisk, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
Japan Coronary Stents Market Analysis
The Japan Coronary Stents Market is expected to witness growth from $702 Mn in 2022 to $1058 Mn in 2030 with a CAGR of 5.25% for the forecasted year 2022-2030. The early identification and treatment of coronary artery disease in Japan are projected to be driven by increased access to healthcare and improved heart health awareness, opening up the potential for manufacturers in the coronary stent market. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Terumo Corporation, Fukuda, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
Italy Coronary Stents Market Analysis
The Italy Coronary Stents Market is expected to witness growth from $271 Mn in 2022 to $378 Mn in 2030 with a CAGR of 4.25% for the forecasted year 2022-2030. Italy's growing elderly population and high prevalence of risk factors like smoking, hypertension, and diabetes are contributing to an increase in the incidence of coronary artery disease. Because of this, there is a rising need for coronary stents. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Sorin Group, Invatec, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.